ETFs positioned on Lotus Pharmaceutical Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
0.01% 4 M€ -4.41% -
0.01% 99 M€ +2.61% -
0.00% 7 M€ +0.11% -
Logo Lotus Pharmaceutical Co., Ltd.
Lotus Pharmaceutical Co Ltd is a Taiwan-based company mainly engaged in the manufacture and sale of generic drugs. The products are mainly solid preparations such as tablets and capsules. The main products include oral anti-cancer drugs, cardiovascular disease drugs, central nervous system drugs, women's health products, osteoporosis drugs and mental disease drugs. The Company is also engaged in the drug research, development and clinical testing business, as well as the product licensing business. The Company mainly distributes products in Taiwan, South Korea, the United States, China mainland, Japan, Europe and Southeast Asia markets.
Employees
1,099
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
270.50TWD
Average target price
394.80TWD
Spread / Average Target
+45.95%
Consensus
  1. Stock Market
  2. Equities
  3. 1795 Stock
  4. ETFs Lotus Pharmaceutical Co., Ltd.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW